ClinicalTrials HQ

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Active, not recruiting · NCT03436654 · Registry updated 2026-04-27
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic AdenocarcinomaGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderActive, not recruitingPhase 22026-04-27NCT03436654

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Dana-Farber Cancer Institute324
Memorial Sloan Kettering Cancer Center753

11 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cleveland ClinicClevelandUnited States558
Dana Farber Cancer InstituteBostonUnited States133
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking RidgeUnited States131
Memorial Sloan Kettering Bergen (Limited Protocol Activities)MontvaleUnited States184
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Memorial Sloan Kettering Commack (Limited Protocol Activities)CommackUnited States26
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)MiddletownUnited States186
Memorial Sloan Kettering Nassau (Limited Protocol Activities)UniondaleUnited States120
Memorial Sloan Kettering Westchester (Limited Protocol Activities)HarrisonUnited States166
Northwestern UniversityEvanstonUnited States53
University of ChicagoChicagoUnited States312